B-type natriuretic peptide: Where are we?

Annali Italiani di Medicina Interna

Volumn 20, Issue 3, 2005, Pages

  Nozzoli, Carlo ^a  

^a SOD Medicina Generale 1   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

BLOOD; CONGESTIVE HEART FAILURE; DIFFERENTIAL DIAGNOSIS; EMERGENCY; HUMAN; NOTE; SENSITIVITY AND SPECIFICITY;

BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; EMERGENCIES; HEART FAILURE, CONGESTIVE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; SENSITIVITY AND SPECIFICITY;

EID: 33644635229     PISSN: 03939340     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (17)

1. McCullough PA, Philbin EF, Spertus JA, et al. Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) Study. J Am Coll Cardiol 2002; 39: 60-9.
2. Jaarsma T, Halfens R, Huijer Abu-Saad H, et al. Effects of education and support on self-care and resource utilization in patients with heart failure. Eur Heart J 1999; 20: 673-82.
3. American Heart Association. Heart disease and stroke statistics - 2003 update. Available at www.american-heart.org
4. Coppola A, De Paola G, Suppa M, et al. Variazioni della concentrazione plasmatica del peptide natriuretico di tipo B in urgenza nella fibrillazione atriale parossistica, nell'edema polmonare acuto, nella sindrome coronarica acuta e nella cardiomiopatia dilatativa. Ann Ital Med Int 2005; 20: 167-86.
5. Mueller C, Scholer A, Laule-Kilian K, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004; 350: 647-54.
6. Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure (Breathing Not Properly study). N Engl J Med 2002; 350: 347-54.
7. Dao Q, Krishnaswamy P, Kazanegra R, et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001; 37: 379-85.
8. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgement in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) multinational study. Circulation 2002; 106: 416-22.
9. Maisel AS, Hollander JE, Guss D, et al. Primary results of the Rapid Emergency Department Heart failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency decision making, and outcomes in patients presenting with shortness of breath. J Am Coll Cardiol 2004; 44: 1328-33.
10. McCullough PA, Duc P, Omland T, et al. B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. Am J Kidney Dis 2003; 41: 571-9.
11. Troughton RW, Frampton CM, Yandle TG. Treatment of heart failure guided by plasma aminoterminal brain peptide (N-BNP) concentrations. Lancet 2000; 355: 1126-30.
12. Cheng V, Kazanagra R, Garcia A, et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001; 37: 386-91.
13. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-41.
14. Verdiani V, Nozzoli C, Bacci F, et al. Predischarge B-type peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail 2005; 7: 566-71.
15. Nieminen MS, Bohm M, Cowie RR, et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 384-416.
16. Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005). The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26: 1115-40.
17. Emdin M, Clerico A, Clemenza F, et al. Recommendations for the clinical use of cardiac natriuretic peptides. Ital Heart J 2005; 6: 430-46.